Civica selects next CEO

Ned McCoy was selected as the next president and CEO of Civica, a nonprofit generic drug company formed by several major health systems.

Mr. McCoy, Civica's COO, will succeed Martin VanTrieste at the helm, effective June 1, according to a news release. Mr. VanTrieste, who came out of retirement four years ago to lead Civica, will continue serving on the company's board.

The leadership transition comes as Civica is building a drug manufacturing facility in Petersburg, Va., which is expected to be operational in early 2024. In March, the company also announced plans to manufacture and distribute three insulins at a discounted price.

Before joining Civica, Mr. McCoy worked at Abbott for more than three decades, according to the release. 

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars